Docusign, Inc. (DOCU) · Sep 3, 2026 · Earnings

Docusign beats Q2 estimates and raises FY27 outlook, but ARR growth stays modest

Beat — Non-GAAP diluted EPS $1.16 vs ~$1.08-$1.09 consensus; revenue $875.7M vs ~$867.2M

Docusign exceeded Q2 revenue and adjusted EPS expectations while lifting FY27 revenue and ARR-growth targets, giving AI claims measurable support.

The quarter cleared a lowered-but-still-positive market bar. Published estimates were roughly $867.2 million of revenue and $1.08-$1.09 of non-GAAP diluted EPS; Docusign delivered $875.7 million and $1.16, respectively. That is about a 1% revenue beat and a roughly 6%-7% adjusted-EPS beat, making this a genuine earnings Beat rather than merely a strong-looking year-over-year comparison.

MetricQ2 FY27Q2 FY26Market expectation / change
Revenue$875.7M$800.6M~$867.2M consensus
Non-GAAP diluted EPS$1.16$0.92~$1.08-$1.09 consensus
Non-GAAP operating margin31.6%29.8%Up 180 bps YoY
Free cash flow$295.8M$217.6MUp 36% YoY
Non-GAAP gross margin81.7%82.0%Down 30 bps YoY
Diluted shares193.1M211.0MDown 8.5% YoY

Profitability and cash generation did more of the work than topline acceleration. Revenue rose 9.4% year over year, while non-GAAP operating margin expanded to 31.6% and free-cash-flow margin reached 34% (Income Statement; Reconciliation of operating expenses; Computation of free cash flow). The EPS beat was also helped by substantially fewer diluted shares, reflecting the company’s repurchase program rather than a step-change in underlying revenue growth.

Management raised the forward framework, which is the clearest incremental signal. Full-year revenue guidance moved to $3.499-$3.507 billion from the prior $3.490-$3.502 billion range, while ARR growth guidance rose to 8.50%-9.00% from 8.25%-8.75% based on the prior outlook. The company also raised its Q3 revenue range to $886-$890 million. The release explicitly says, “Docusign is raising its outlook as AI accelerates momentum across the business.” 〔0〕

The net read is a meaningful beat with improving execution, not a breakout-growth reset. AI and IAM activity now have financial support through the raised outlook and margin expansion, but the company still guides to only about 9% revenue growth and 8.75% ARR growth at the midpoint. Gross margin slipped year over year, and the filing provides no new quantified disclosure showing that AI products are yet materially accelerating the growth rate. Versus expectations, however, the combination of an EPS and revenue beat, higher guidance, stronger cash flow, and lower share count lands clearly above the bar.

What to watch next

Q2 10-Q filing, September 4, 2026

Original filing on SEC EDGAR

Docusign beats Q2 estimates and raises FY27 outlook, but ARR growth stays modest | DOCU Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.